In the BRCA1/2-negative study sample, 9.4% (32/340) of the patients with mBC, all unilaterally affected, carried at least one PV in the 23 (suspected) non-BRCA1/2 cancer predisposition genes (Figure 1). This evidence concerns the gene BRCA1 and cancer.